Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZMYND11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A21-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EHMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WTH3DI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIPK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KBTBD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PABPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLGAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGAV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX7A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on